Program GoalsCOVID pneumonia represents the active inflammation of the pulmonary parenchyma that is caused by SARS-CoV-2, the coronavirus that has caused the COVID-19 pandemic. Millions of patients have been affected worldwide and hospitalizations have occurred all over the globe. The condition can range from mild to severe and represents a challenge for clinicians. COVID pneumonia has a complex pathophysiology, with profound derangements in ventilation and perfusion that causes profound and sometimes difficult to treat acute hypoxemic respiratory failure. International collaboration has put together multiple randomized clinical trials that have provided evidence-based medicine for the treatment of this illness. Despite the above there is still significant morbidity and mortality associated with COVID pneumonia. It is important for clinicians to recognize this entity, and follow closely the rapidly changing recommendations regarding management and treatment. Target AudienceThis activity is intended for the following medical professionals who have a clinical interest in COVID pneumonia caused by SARS-CoV-2: Pulmonologists; Critical Care Specialists; Internal Medicine and Primary Care Physicians; Physician Assistants; Advanced Practice Nurses; and Nurse Practitioners. Learning ObjectivesAfter completion of this activity, participants should be able to:
FacultyDaniel Salerno, MD, MS Educational Activity AgendaFront Matter and Registration (5 minutes) Release and Expiration DatesRelease Date: November 9, 2022 Disclosure PolicyIt is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D., Office for Continuing Medical Education that anyone in a position to control the content of a certified educational activity must disclose any financial relationships with ineligible companies within the prior 24 months. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” Speakers must also disclose discussions of unlabeled/ unapproved uses of drugs or devices during their presentations. The Lewis Katz School of Medicine at Temple University has policies in place that will identify and mitigate all conflicts of interest prior to the educational activity. Detailed disclosure will be communicated to learners prior to the activity. Faculty DisclosuresThe faculty disclosed the following financial relationships with ineligible companies related to the content of this educational activity. Daniel Salerno, MD None of the faculty for this educational activity have relevant financial relationships to disclose with ineligible companies. Course Directors, Planners, Reviewers, and Managers/CME Staff DisclosuresThe course directors, planners, reviewers, and managers/CME staff disclosed the following financial relationships with ineligible companies related to the content of this educational activity: Daniel Salerno, MD, MS (Planner and Faculty) Michael Henderson (Manager) *None of the course directors, planners, reviewers, and managers/CME staff for this educational activity have relevant financial relationships to disclose with ineligible companies. Accreditation StatementLewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians. Certification StatementLewis Katz School of Medicine at Temple University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. How to Obtain CME CreditAttendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™. To receive credit, the course must be completed between November 9, 2022 - November 9, 2024. Participation in this activity should be completed in approximately 1.0 hour(s). Please follow these steps in order to receive CME/CE credit for viewing the webcast: • Read all of the CME/CE accreditation information above. After successfully completing the online test and/or evaluation, your application will be immediately processed, and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity. Should you have any CME questions regarding this activity, please contact: The Albert J. Finestone, MD Office for Continuing Medical Education No commercial support has been provided for this activity.1 System RequirementsTo view this educational activity you, will need a web browser with JavaScript and either Flash or HTML5 enabled. Nearly all modern web browsers will work. If you have special accommodations that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787 or cme@temple.edu. CopyrightCopyright © 2022. Temple University. Philadelphia, PA. All rights reserved. | ||
Web interface provided by Dane Garvin Ltd.
|